PL4247833T3 - Synteza ligandów antygenu błonowego swoistego dla prostaty (psma) - Google Patents

Synteza ligandów antygenu błonowego swoistego dla prostaty (psma)

Info

Publication number
PL4247833T3
PL4247833T3 PL21815500.0T PL21815500T PL4247833T3 PL 4247833 T3 PL4247833 T3 PL 4247833T3 PL 21815500 T PL21815500 T PL 21815500T PL 4247833 T3 PL4247833 T3 PL 4247833T3
Authority
PL
Poland
Prior art keywords
psma
prostate
ligands
synthesis
specific membrane
Prior art date
Application number
PL21815500.0T
Other languages
English (en)
Inventor
Fritz Andreae
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL4247833T3 publication Critical patent/PL4247833T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL21815500.0T 2020-11-19 2021-11-19 Synteza ligandów antygenu błonowego swoistego dla prostaty (psma) PL4247833T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20208556 2020-11-19
PCT/EP2021/082323 WO2022106629A1 (en) 2020-11-19 2021-11-19 Synthesis of prostate specific membrane antigen (psma) ligands

Publications (1)

Publication Number Publication Date
PL4247833T3 true PL4247833T3 (pl) 2026-02-23

Family

ID=73497545

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21815500.0T PL4247833T3 (pl) 2020-11-19 2021-11-19 Synteza ligandów antygenu błonowego swoistego dla prostaty (psma)

Country Status (9)

Country Link
US (1) US20240025866A1 (pl)
EP (2) EP4247833B1 (pl)
JP (1) JP7837971B2 (pl)
CN (1) CN116438165A (pl)
ES (1) ES3048365T3 (pl)
HR (1) HRP20251362T1 (pl)
PL (1) PL4247833T3 (pl)
RS (1) RS67468B1 (pl)
WO (1) WO2022106629A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230155494A (ko) * 2021-02-26 2023-11-10 테릭스 파마슈티컬스 (이노베이션스) 피티와이 엘티디 글루타메이트-우레아-라이신 유래(gul 유래) 전립선-특이적 막 항원(psma) 표적화 접합체의 고체상 합성 및 치료 및/또는 진단제의 전구체로서 이들의 용도
CN115925586A (zh) * 2022-11-01 2023-04-07 青岛蓝谷多肽生物医药科技有限公司 一种靶向psma的母体及其衍生物的制备方法
JP7849338B2 (ja) * 2023-09-22 2026-04-21 株式会社三共 遊技機
WO2025088147A1 (en) * 2023-10-27 2025-05-01 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Theranostic psma-targeting ligands for the diagnosis and treatment of psma-expressing cancers and their solid phase synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109134602B (zh) * 2018-08-28 2021-07-02 兰州大学 一种高效的前列腺特异性膜抗原配体psma-617的固相制备方法
JP7604397B2 (ja) * 2019-05-20 2024-12-23 エンドサイト・インコーポレイテッド Psmaコンジュゲートの調製方法

Also Published As

Publication number Publication date
RS67468B1 (sr) 2025-12-31
EP4247833B1 (en) 2025-09-24
CN116438165A (zh) 2023-07-14
JP7837971B2 (ja) 2026-03-31
JP2023550371A (ja) 2023-12-01
US20240025866A1 (en) 2024-01-25
HRP20251362T1 (hr) 2025-12-19
ES3048365T3 (en) 2025-12-10
WO2022106629A1 (en) 2022-05-27
EP4663652A1 (en) 2025-12-17
EP4247833A1 (en) 2023-09-27
EP4247833C0 (en) 2025-09-24

Similar Documents

Publication Publication Date Title
EP4247833C0 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGAND SYNTHESIS
EP3481804A4 (en) IMPROVED SYNTHESIS OF RADIOACTIVELY MARKED PROSTATE-SPECIFIC MEMBRANE-ANTIBODY (PSMA) INHIBITOR [18F] DCFPYL
EP4104578A4 (en) ENHANCED SURVEY REFERENCE SIGNAL RESOURCE CONFIGURATIONS
IL292754A (en) Method of synthesis
EP4315888A4 (en) Sidelink positioning reference signal resource configuration
EP4128891B1 (en) POSITIONING SIGNAL PRIORITIZATION
IL289039A (en) Prostate specific membrane antigen (psma) ligands and uses thereof
EP3996387B1 (en) FLAT DIAPHRAGM SPEAKER
EP4308109A4 (en) SYNTHESIS OF ENDOQUINOL-LIKE QUINOLONES
IL284441A (en) One pot synthesis of sets of oligonucleotides
EP4402147A4 (en) SYNTHESIS OF FLUOROALKYL TIN PRECURSORS
DE112020007326A5 (de) Mikromembranpumpeinrichtung
EP4396159A4 (en) NIROGACESTAT SYNTHESIS
EP4251555A4 (en) A davit assembly
EP3987514C0 (en) SCENE-BASED AUDIO DATA CORRELATION FOR PSYCHOACOUSTIC AUDIO CODING
JP1747765S (ja) スピーカー
EP4364495A4 (en) Sounding reference signal (srs) resource set configuration for asymmetric panels
IL314221A (en) Synthesis of a kif18a inhibitor
EP4408468A4 (en) MULTIPLE FORMATS OF MOLECULAR COMPLEXES
PL4121408T3 (pl) Synteza pochodnych kapsaicyny
JOP20250050A1 (ar) ربيطات مستضد الغشاء النوعي للبروستات (psma) واستخداماتها
EP4297804A4 (en) SOLID PHASE SYNTHESIS OF GLUTAMATE-UREA-LYSINE DERIVATIVE CONJUGATES (GUL DERIVATIVES) TARGETING PROSTATIC MEMBRANE ANTIGEN (PSA) AND THEIR USE AS PRECURSORS OF THERAPEUTIC AND/OR DIAGNOSTIC AGENTS
IL310985A (en) Improved flow synthesis
DK4114793T3 (da) Fremgangsmåde til fremstillingen af syntesegas
IL313405A (en) Synthesis of glufosinate using a hydantoinase-based process